The content of this article is more than 5 years old. Please be aware that information provided may no longer be accurate, up-to-date, or relevant.
Meg Gaines was provisionally appointed to the National Academy of Sciences, Engineering, and Medicine committee entitled “Ensuring Patient Access to Affordable Drug Therapies.” The committee will examine patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design.
Submitted by Karen Koethe on October 21, 2016
This article appears in the categories: Activities & Scholarship
Related employee profiles: Martha (Meg) Gaines
